FORTRESS BIOTECH INC's ticker is FBIO and the CUSIP is 34960Q109. A total of 87 filers reported holding FORTRESS BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $36,000 | -45.5% | 26,240 | 0.0% | 0.00% | – |
| Q4 2021 | $66,000 | -24.1% | 26,240 | -3.0% | 0.00% | – |
| Q3 2021 | $87,000 | -10.3% | 27,040 | 0.0% | 0.00% | – |
| Q2 2021 | $97,000 | -9.3% | 27,040 | -10.7% | 0.00% | – |
| Q1 2021 | $107,000 | -54.9% | 30,295 | -59.4% | 0.00% | – |
| Q4 2020 | $237,000 | -10.9% | 74,683 | +13.4% | 0.00% | -100.0% |
| Q3 2020 | $266,000 | +358.6% | 65,868 | +206.6% | 0.00% | – |
| Q2 2020 | $58,000 | +123.1% | 21,480 | +48.1% | 0.00% | – |
| Q1 2019 | $26,000 | +116.7% | 14,506 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -47.8% | 14,506 | 0.0% | 0.00% | – |
| Q3 2018 | $23,000 | -46.5% | 14,506 | 0.0% | 0.00% | – |
| Q2 2018 | $43,000 | -49.4% | 14,506 | -22.2% | 0.00% | – |
| Q1 2018 | $85,000 | +14.9% | 18,655 | 0.0% | 0.00% | – |
| Q4 2017 | $74,000 | -9.8% | 18,655 | 0.0% | 0.00% | – |
| Q3 2017 | $82,000 | -7.9% | 18,655 | 0.0% | 0.00% | – |
| Q2 2017 | $89,000 | – | 18,655 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,750,000 | $12,075,000 | 2.26% |
| Nantahala Capital Management | 8,140,794 | $26,213,000 | 0.83% |
| SHIKIAR ASSET MANAGEMENT INC | 694,500 | $2,236,000 | 0.63% |
| PERKINS CAPITAL MANAGEMENT INC | 128,805 | $415,000 | 0.26% |
| Telemetry Investments, L.L.C. | 55,000 | $177,000 | 0.24% |
| CPWM, LLC | 514,767 | $1,658,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 187,178 | $603,000 | 0.06% |
| Spotlight Asset Group, Inc. | 10,700 | $34,000 | 0.02% |
| Summit Global Investments | 44,900 | $145,000 | 0.01% |
| Virtu Financial LLC | 25,714 | $83,000 | 0.01% |